Compare Humana Inc (HUM) vs Blue Owl Capital Inc. Class A Common Stock (OWL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Blue Owl Capital Inc. Class A Common Stock — how do they compare? Humana Inc trades at $428 (market cap $51.32B), while Blue Owl Capital Inc. Class A Common Stock trades at $8.8 (market cap $6.01B). The key difference: Humana Inc is far larger — about 8.5× Blue Owl Capital Inc. Class A Common Stock's market cap, and Blue Owl Capital Inc. Class A Common Stock pays the higher dividend (10.35%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Blue Owl Capital Inc. Class A Common Stock for 0 Days on average.
| HUM | OWL | |
|---|---|---|
Market Cap | $51.32B | $6.01B |
Volume | 917,121 | 24,327,195 |
Sector | Health | Financials |
52-Week High | $433.50 | $17.17 |
52-Week Low | $163.67 | $8.23 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | $58.68B | $10.19B |
Dividend Yield | 0.83% | 10.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $420.03, down 3.11% today, with a bullish technical signal and strong institutional interest. The company shows consistent revenue growth from $92.9B in 2022 to $129.7B in 2025, though net margins have compressed to 0.88%. Recent earnings beats and a Barclays upgrade to $515 target highlight positive momentum, while technical indicators show support at $411 and resistance at $440.
Outlook remains positive with analyst consensus target of $469.89 offering 12% upside, though risks include margin pressure, Medicare Advantage plan changes, and regulatory scrutiny. The stock presents a balanced opportunity with strong fundamentals offset by execution challenges in a competitive healthcare market.
Blue Owl Capital (OWL) trades at $9.29, down 0.54% on the day, with neutral technical indicators showing support at $9 and resistance at $10. The company reported mixed quarterly earnings, beating expectations in Q4 2025 and Q2 2026 but missing in Q1 2026, with Q3 2026 results pending. Revenue growth remains steady at $2.9B in 2025, projected to $3.0B in 2026, though net margins are thin at 2.71%. Analyst sentiment is positive with 63% buy ratings and a $11.01 consensus target, but private credit fund redemptions and loan quality concerns present headwinds.
OWL offers value at a discount to analyst targets with strong institutional backing, but investors face risks from high P/E valuation (77.42), exposure to private credit volatility, and competitive pressures. The stock's 9.8% dividend yield and embedded fee growth from $31.1B in committed capital support upside, though execution on portfolio quality and redemption management will dictate near-term performance. Neutral outlook with cautious optimism pending Q3 earnings clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Blue Owl Capital Inc. Class A Common Stock
Blue Owl Capital Inc. is an alternative asset manager that invests across credit, real assets, and GP strategic capital strategies, providing private capital solutions to businesses and to institutional and individual investors.
Read more on OWL →
